FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
FSD Pharma Inc. announced results of its annual meeting held on July 22, 2024. Shareholders represented 100% of Class A shares and 35.45% of Class B shares.
Toronto, Ontario – (Newsfile Corp. – July 23, 2024) – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) (“FSD Pharma” or the “Company”), a leading biopharmaceutical company focused on innovative biotech solutions, is pleased to announce the outcomes of its annual general and special meeting of shareholders held on Monday, July 22, 2024, at 801-1 Adelaide Street East, Toronto, ON M5C 2V9 (“AGSM”).
Shareholders representing 72 Class A multiple voting shares (the “Class A Multiple Voting Shares”) and 15,960,879 Class B subordinate voting shares (the “Class B Subordinate Voting Shares”) attended the AGSM either in person or by proxy. These shares accounted for 100% and 35.45% of the votes attached to the Class A and Class B shares, respectively. Each Class A Multiple Voting Share entitles the holder to 276,660 votes on all matters.
All nominees listed in the Company’s management information circular dated June 10, 2024, were elected as directors of the Company. Each director will serve until the next annual meeting of shareholders or until their successor is duly elected or appointed.
Toronto, Ontario – (Newsfile Corp. – July 23, 2024) – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) (“FSD Pharma” or the “Company”), a leading biopharmaceutical company focused on innovative biotech solutions, is pleased to announce the outcomes of its annual general and special meeting of shareholders held on Monday, July 22, 2024, at 801-1 Adelaide Street East, Toronto, ON M5C 2V9 (“AGSM”).
Shareholders representing 72 Class A multiple voting shares (the “Class A Multiple Voting Shares”) and 15,960,879 Class B subordinate voting shares (the “Class B Subordinate Voting Shares”) attended the AGSM either in person or by proxy. These shares accounted for 100% and 35.45% of the votes attached to the Class A and Class B shares, respectively. Each Class A Multiple Voting Share entitles the holder to 276,660 votes on all matters.
All nominees listed in the Company’s management information circular dated June 10, 2024, were elected as directors of the Company. Each director will serve until the next annual meeting of shareholders or until their successor is duly elected or appointed.
The elected directors are as follows:
[List of elected directors]
In addition to the election of directors, shareholders took the following actions at the AGSM:
Re-appointment of Auditor: MNP LLP was re-appointed as the Company’s auditor, with the directors authorized to fix the auditor’s remuneration.
Share Consolidation Resolution: Shareholders approved a resolution enabling the board to consolidate up to 100 pre-consolidation Class A and Class B shares into one post-consolidation share, at the board’s discretion.
Name Change Resolution: A special resolution was approved to allow the board to change the Company’s name, as determined by management.
Article Ratification: Class B shareholders, excluding those holding Class A shares, approved and ratified amendments to the Company’s articles to expand the definition of “Permitted Holders.”
Class A Share Issuance: Class B shareholders, excluding those holding Class A shares, passed a resolution authorizing the board to issue additional Class A shares up to the regulatory maximum.
For more details on these resolutions and other matters, refer to the Company’s management information circular dated June 10, 2024, available on SEDAR+ at www.sedarplus.ca. Voting results can also be found under the Company’s SEDAR+ profile.